Cleft Palate
|
0.300 |
Biomarker
|
disease |
CTD_human |
Craniofacial abnormalities resulting from targeted disruption of the murine Sim2 gene.
|
12203729 |
2002 |
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Craniofacial abnormalities resulting from targeted disruption of the murine Sim2 gene.
|
12203729 |
2002 |
Cleft palate, isolated
|
0.300 |
Biomarker
|
disease |
CTD_human |
Craniofacial abnormalities resulting from targeted disruption of the murine Sim2 gene.
|
12203729 |
2002 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Hematocrit procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Hemoglobin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Down Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Single-minded 2 (Sim2), a transcriptional repressor, is reportedly involved in diseases that impair learning and memory, such as Down syndrome (DS) and Alzheimer's disease.
|
25319570 |
2015 |
Complete Trisomy 21 Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Single-minded 2 (Sim2), a transcriptional repressor, is reportedly involved in diseases that impair learning and memory, such as Down syndrome (DS) and Alzheimer's disease.
|
25319570 |
2015 |
Down Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Here we studied functional genetic polymorphisms (fSNP) in ETS2 and SIM2 encoding genes in a group of patients and control subjects to better understand association of these variants with DS phenotypes.
|
23343470 |
2013 |
Complete Trisomy 21 Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Here we studied functional genetic polymorphisms (fSNP) in ETS2 and SIM2 encoding genes in a group of patients and control subjects to better understand association of these variants with DS phenotypes.
|
23343470 |
2013 |
Down Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results suggest that MAD2B may mediate Sim2 function during development in CNS and thereby play a critical role in pathophysiological mechanisms in DS.
|
22660985 |
2012 |
Complete Trisomy 21 Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results suggest that MAD2B may mediate Sim2 function during development in CNS and thereby play a critical role in pathophysiological mechanisms in DS.
|
22660985 |
2012 |
Down Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Significantly lower frequency of SIM2 C-G haplotype (rs2073601-rs2073416) was noticed in individuals with DS (P value =0.01669) and their fathers (P value=0.01185).
|
22048266 |
2011 |
Complete Trisomy 21 Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Significantly lower frequency of SIM2 C-G haplotype (rs2073601-rs2073416) was noticed in individuals with DS (P value =0.01669) and their fathers (P value=0.01185).
|
22048266 |
2011 |
Down Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
SIM2 was initially identified by positional cloning on chromosome 21 and is thought to contribute to the etiology of trisomy-21 [Down syndrome (DS)].
|
16840439 |
2007 |
Down Syndrome
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
We previously localized SIM2 in a chromosome 21 critical region for Down syndrome (DS).
|
15946822 |
2005 |
Down Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Drebrin has been reported to be engaged in dendritic-cytoskeleton modulation at synapses, and such a novel NXF signaling system on neural gene promoter may be a molecular target of the adverse effects of Sim2 in the mental retardation of Down's syndrome.
|
14701734 |
2004 |
Complete Trisomy 21 Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Drebrin has been reported to be engaged in dendritic-cytoskeleton modulation at synapses, and such a novel NXF signaling system on neural gene promoter may be a molecular target of the adverse effects of Sim2 in the mental retardation of Down's syndrome.
|
14701734 |
2004 |
Down Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.
|
12676991 |
2003 |
Down Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
BACH1 was significantly overexpressed in fetal DS (p < 0.008) as compared to controls whereas RUNX1 and ERG proteins were comparable between groups, and SIM2 l was not detectable in any specimen.
|
15068251 |
2003 |
Complete Trisomy 21 Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
BACH1 was significantly overexpressed in fetal DS (p < 0.008) as compared to controls whereas RUNX1 and ERG proteins were comparable between groups, and SIM2 l was not detectable in any specimen.
|
15068251 |
2003 |
Complete Trisomy 21 Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.
|
12676991 |
2003 |
Down Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There are no previous reports of this combination, but there are genetic links between Down syndrome and midline defects concerning the Drosophila single-minded (sim) gene.
|
12174971 |
2002 |
Complete Trisomy 21 Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There are no previous reports of this combination, but there are genetic links between Down syndrome and midline defects concerning the Drosophila single-minded (sim) gene.
|
12174971 |
2002 |